AGP Picks
View all

Contract sterilization to dominate a $8 billion market by 2030

Oct. 19, 2026
Contract sterilization to dominate a $8 billion market by 2030
By AI, Created 12:55 UTC, Oct 19, 2026, AGP -

Contract sterilization services are projected to capture 78% of the global sterilization services market by 2030 as healthcare providers and manufacturers outsource more sterility work. The market is forecast to top $8 billion by 2030, driven by infection control needs, regulatory pressure and demand for scalable capacity.

Why it matters: - Contract sterilization is becoming the default option for medical device makers, pharmaceutical companies and healthcare providers that need validated sterility without building costly in-house capacity. - The category’s growth reflects broader pressure to reduce infection risk, meet regulatory requirements and handle more complex products. - The market is projected to reach 78% share for contract sterilization services by 2030, making it the clear center of gravity in the sector.

What happened: - The Business Research Company published its Contract sterilization services Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Oct. 16, 2026. - The report projects the sterilization services market will surpass $8 billion by 2030. - The report says contract sterilization services will account for 78% of the market, or about $6 billion, by 2030. - The broader medical laboratory services market is forecast to reach about $237 billion in 2030. - Sterilization services are expected to represent nearly 0.1% of the larger healthcare services market, which the report puts at $11,335 billion by 2030. - The market is forecast to grow at an 8% compound annual growth rate through 2030.

The details: - North America is projected to be the largest regional market in 2030 at $3.5 billion, up from $2.5 billion in 2025. - North America is expected to grow at a 7% CAGR through 2030. - The United States is projected to be the largest national market in the region at $3.2 billion in 2030, up from $2.3 billion in 2025. - The U.S. market is also forecast to grow at a 7% CAGR. - Growth in North America is linked to outsourcing by medical device and pharmaceutical companies, wider use of single-use medical products, tighter sterility rules and investment in sterilization infrastructure. - The U.S. market is supported by demand for specialized sterilization for complex medical devices, more outsourcing by healthcare producers, regulatory compliance needs, expanding biotech and pharmaceutical research and modernization of healthcare facilities. - Hospital-acquired infections are a major growth driver, as providers increase infection prevention efforts and stricter sterilization protocols. - The report says this infection-control trend will contribute about 2.3% to annual market growth. - Medical device reprocessing is adding demand as hospitals reuse more instruments to cut costs and reduce waste. - Reprocessed devices still require validated sterilization, and the report says this trend will add about 2.1% annual growth. - New sterilization equipment is improving cycle consistency, monitoring, automation and throughput. - The report says technology upgrades will add about 1.9% annual growth. - Sterilization validation and contract sterilization together are expected to add more than $3 billion in market value by 2030. - Contract sterilization alone is projected to grow by $2 billion from 2025 to 2030. - Validation services are projected to add another $1 billion over the same period. - The market is segmented by sterilization method, including X-ray irradiation, ethylene oxide, gamma, electron beam and steam sterilization. - Delivery modes are split between on-site and off-site services. - End users include hospitals and clinics, medical device companies, pharmaceutical and biotechnology firms, and other healthcare customers. - Rapid biological indicator testing is speeding up sterility validation and product release. - In September 2025, Nelson Laboratories LLC launched RapidCert, a rapid BI testing service that reduces incubation time from seven days to 48 hours. - The market is moderately fragmented, with the top 10 companies holding about 28% of revenue in 2024. - STERIS PLC held the largest share in 2024 at 8%, followed by Sotera Health Company at 7%, Ecolab Inc. at 6% and Belimed AG at 6%. - Advanced Sterilization Products held 0.4% of the market in 2024. - E-BEAM Services Inc., SteriTek Inc. and Medistri SA each held 0.2%. - MICROTROL Sterilisation Services Pvt. Ltd. and BGS Beta-Gamma-Service GmbH & Co. KG each held 0.1%.

Between the lines: - The market’s fragmentation suggests no single company controls the category, even as the largest players maintain an edge through global networks, partnerships and broader service offerings. - Outsourcing is the clearest structural trend, because healthcare manufacturers appear to prefer paying for specialized capacity rather than funding their own sterilization infrastructure. - Regulatory scrutiny and the need for documented compliance favor providers with validated processes, automation and quality-control systems. - The rise of rapid BI testing points to a market shift toward faster release cycles and tighter process control.

What's next: - Companies are expected to expand capacity, add regional presence and pursue partnerships as outsourced demand rises. - Providers are also likely to keep investing in low-temperature methods, automation and advanced monitoring systems. - Contract sterilization should remain the leading segment through 2030 as manufacturers continue to outsource sterility-critical work. - More information

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

US Manufacturing Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

US Manufacturing Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.